MedX Health Corp, a leader in tele dermatology, has announced a Memorandum of Understanding (MOU) and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a privately owned corporate health and primary care services company in the United Kingdom.
The Mississauga, Ontario-based medical device and software company, which is focused on skin health, said the pilot will span three to six months and involve nearly 600 patients across two of Health Partner’s sites. On successful completion of the pilot, the MedX DermSecure Screening Platform will be made available to Health Partners’ over two million patients.
The agreement is the latest initiative in MedX's global commercialization strategy and follows pilots recently launched across the Europe and Middle East region.
READ: MedX Health launches two more screening services locations in Ottawa
Health Partners employs over 700 people with telehealth, mobile, and on-site operations across the UK and Ireland. It has a broad client base of corporates, government agencies, insurers, health trusts, pension funds, and individuals.
"Health Partners' Clinical Team constantly strives to identify leading technological innovations that offer the highest level of support to our two million-plus patients," Health Partners managing director Andrew Noble said in a statement.
"MedX's leading skin assessment technology allows dermatologists to not only make more accurate diagnoses of pigmented lesions and moles, but to do that remotely and quickly," he added.
In addition to expanding its DermSecure Screening Platform network globally, MedX has focused on building a presence in multiple verticals such as pharmacies, medical clinics, medical scanning clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX's expansion into a new vertical - occupational health and wellbeing services.
Meanwhile, Naman Demaghlatrous who is the managing director, Europe, Middle East and Africa, for MedX Health Partners said the partnership expands the company’s footprint in the EMEA region.
“We continue to execute on our strategy to identify strategic partnerships in the region that will allow us to grow our business and save lives," noted Demaghlatrous.
Health Partners will pilot MedX's high-definition image-capture technology, SIAscopy, and its secure, cloud-based patient management system, DermSecure, which transmits and stores patient data throughout the assessment process.
MedX's SIAscopy captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. The technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours.
"We are honoured to be working with Health Partners ... According to Health and Safety Executive-commissioned research, there are more than 3,000 cases of skin cancer annually in the construction industry alone. We are delighted to be entering the occupational health services market with a leader in the industry," said Mike Druhan, MedX president, Dermatology Services.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive